Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Kedudukan dalam Saham #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Harga Saham
$152.40
Modal Pasaran
$376.40B
Perubahan (1 hari)
12.48%
Perubahan (1 tahun)
79.44%
Negara
US
Perdagangan Merck & Co., Inc. (MRK)

Kategori

Nisbah P/E bagi Merck & Co., Inc. (MRK)
Nisbah P/E pada August 2026 TTM: 107.81
Menurut laporan kewangan dan harga saham terkini Merck & Co., Inc., nisbah P/E semasa (TTM) ialah 107.81. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 14.72.
Sejarah nisbah P/E bagi Merck & Co., Inc. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) 107.81 645.57%
2025 14.46 -1.74%
2024 14.72 -98.11%
2023 778.71 3,924.61%
2022 19.35 30.21%
2021 14.86 -46.79%
2020 27.92 23.57%
2019 22.60 -25.59%
2018 30.37 -49.75%
2017 60.43 53.54%
2016 39.36 24.80%
2015 31.54 144.60%
2014 12.89 -59.36%
2013 31.72 65.59%
2012 19.16 9.91%
2011 17.43 -85.89%
2010 123.55 2,069.42%
2009 5.70 -28.19%
2008 7.93 -78.40%
2007 36.72 79.85%
2006 20.42 41.90%
2005 14.39 23.34%
2004 11.67 -19.12%
2003 14.42 -15.38%
2002 17.04 -3.27%
2001 17.62 -41.63%
2000 30.19 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
39.54 -63.33%
US
30.10 -72.08%
US
70.28 -34.81%
US
22.25 -79.36%
CH
22.23 -79.38%
CH
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.